for the SURPASS-2 Investigators
While the GH increase from CJC-1295/Ipamorelin is more modest than pharmaceutical GH replacement, it operates through the same pathway and avoids the side effect profile associated with exogenous GH administration
Reported changes are often linked to hormone shifts during weight loss, lower energy or nutrition, and GI discomfort, and many people notice improvement as the body adjusts or with dose and lifestyle changes
GLP-1 will induce satiation in animals deprived of food when ghrelin is blocked before administration of GLP-1 (CC Ronveaux, G DeLartigue, and HE Raybould, unpublished results, 2014) and, we have preliminary evidence to suggest that ghrelin restricts GLP-1Rs on VANs to the cytoplasm and that CCK will move GLP-1Rs to the plasma membrane ( Figure 2 )
What makes BPC-157 so unique is that it doesnt override the bodys systems it supports and enhances them, allowing for faster, more complete recovery without the suppression, rebound, or systemic disruption associated with other compounds
Retrieved from Ballini, A., Charitos, I